Subliminal Laser
Therapy for Retinal
Disorders

How to treat retina today?

subliminal laser therapy treatment application

For a quarter of a century, laser photocoagulation has been considered a safe and effective treatment option for macular pathologies. Over the years, the development and introduction of new and innovative macular laser technologies has confirmed that, alongside intravitreal injections, photocoagulation laser therapy still plays a valuable role in the surgeons’ treatment armamentarium.

Today, ophthalmologists can offer their patients enhanced retinal treatment options, with greater safety and efficacy than ever before.

*Image courtesy of Alejandro Filloy Rius, MD, Ph.D. – Tarragona, Spain

retina image subliminal laser therapy treatment

Subliminal laser therapy:

Unlike conventional thermal laser, Subliminal laser therapy is a non-damaging treatment mode based on a train of microsecond pulses.

It involves a series of repetitive laser pulses with intervals (cooling times) and produces a therapeutic treatment effect without inducing scarring or RPE damage on clinical examination during or after treatment.

Its use is dedicated to the treatment of macular diseases.

  • A macular treatment
There remains an unmet need in the treatment of macular diseases. Increasing evidence demonstrates SubLiminal laser therapy to be safe and effective for macular conditions such as DME and CSC.
Learn more
Learn more

Several studies demonstrate that retinal destruction was required to control the neovascularization process in PDR. For peripheral conditions Multispot laser photocoagulation should be favored.

Learn more
Learn more

Easily access to our clinical database

Find our latest clinical data regarding subliminal laser therapy

LATEST CLINICAL DATA

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…
Subliminal laser therapy
Play button

SubLiminal Laser Therapy: Concept and reasons

30/09/2021
Dr Kenneth FONG presents SubLiminal Laser Therapy for macula diseases through the concepts and reasons, during APAO 2021
View
CSC-verteporfin-min

Central Serous Chorioretinopathy: Can it be treated without Visudyne?

03/05/2022
Given the difficulty of obtaining verteporfin for chronic CSCR, it is worth considering subthreshold laser therapy as an alternative given its comparable efficacy and practical advantages. We know that the prognosis for this disease depends on the level of disease progression, so a therapeutic option that allows for an undelayed treatment is extremely interesting.
View
Laser Remains an Effective Option for DME and CSCR Treatments

Laser Remains an Effective Option for DME and CSCR Treatments

16/12/2021
Diabetic macular edema (DME) is the leading cause of irreversible visual loss in the diabetic population. Laser plays a very important role in the treatment of DME despite the use of anti-VEGF agents, said Dr. Victor Chong, consultant ophthalmic surgeon at London Medical, United Kingdom, during a symposium at the recently held APAO 2021 Virtual.
View
CPE Show Daily Day1 V2 Quantel 1

The Argument for Laser in 2021

30/09/2021
When discussing treatment for macular pathologies like diabetic macular edema (DME) and central serous chorioretinopathy (CSCR), injection burden is a term that often appears.
View
RT0921 Quantel Final Revised 1

Formation of the Subthreshold Ophthalmic Laser Society

30/09/2021
Laser photocoagulation has been used in ophthalmology for many years. During photocoagulation, a continuous wave of energy is delivered to the target tissue throughout the entire duration of the laser pulse.
View
CSC-verteporfin-min

Central Serous Chorioretinopathy: Can it be treated without Visudyne?

03/05/2022
Given the difficulty of obtaining verteporfin for chronic CSCR, it is worth considering subthreshold laser therapy as an alternative given its comparable efficacy and practical advantages. We know that the prognosis for this disease depends on the level of disease progression, so a therapeutic option that allows for an undelayed treatment is extremely interesting.
View
Laser Remains an Effective Option for DME and CSCR Treatments

Laser Remains an Effective Option for DME and CSCR Treatments

16/12/2021
Diabetic macular edema (DME) is the leading cause of irreversible visual loss in the diabetic population. Laser plays a very important role in the treatment of DME despite the use of anti-VEGF agents, said Dr. Victor Chong, consultant ophthalmic surgeon at London Medical, United Kingdom, during a symposium at the recently held APAO 2021 Virtual.
View
Access to all our clinical data